Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients

Lung Cancer

Volumn 38, Issue 1, 2002, Pages 31-38

  Fukunaga, Yoko ^a   Bandoh, Shuji ^a   Fujita, Jiro ^a   Yang, Yu ^a,b   Ueda, Yutaka ^a   Hojo, Satoko ^a   Dohmoto, Kazutaka ^a   Tojo, Yasunori ^a   Takahara, Jiro ^a   Ishida, Toshihiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cytokeratin 8; Lung cancer; Metastasis; Non small; Semi quantitative RT PCR

Indexed keywords

CYTOKERATIN 8; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0036806340     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00109-5     Document Type: Article

References (34)

1. Khuri F.R., Herbst R.S., Fossella F.V. Emerging therapies in non-small-cell lung cancer. Annales Oncol. 12:2001;739-744.
2. Hoffman P.C., Mauer A.M., Vokes E.E. Lung cancer. Lancet. 355:2000;479-485.
3. Lazarides E. Intermediate filaments: a chemically heterogeneous developmentally regulated class of proteins. Ann. Rev. Biochem. 5:1982;219-250.
4. Virtanen I., Letho V.P., Lehtonen E., Vartio T., Stenman S., Kurki P. Expression of intermediate filaments in cultured cells. J. Cell Sci. 50:1981;45.
5. Moll R., Franke W.W., Schiller D.L. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 31:1982;11-24.
6. Donald P.J., Cardiff R.D., He D., Kendall K. Monoclonal antibody-porphyrin conjugate for head and neck cancer: The possible magic bullet. Otolaryngol Head Neck Surg. 105:1991;781-787.
7. Godfroid E., Geuskens M., Dupressoir T., Parent I., Szpirer C. Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J. Cell Sci. 99:1991;595-607.
8. Hembrough T.A., Vasudevan J., Allietta M.M., Glass W.F. II, Gonias S.L. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J. Cell Sci. 108:1995;1071-1082.
9. Hembrough T.A., Li L., Gonias S.L. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J. Biol. Chem. 371:1996;25684-25691.
10. Blobel G.A., Moll R., Franke W.W., Vogt-Moykopf I. Cytokeratins in normal lung and lung carcinomas: adenocarcinomas, squamous carcinomas and culture cell lines. Virchows Arch. (Cell Pathol.). 45:1984;409-429.
11. Broers J.L.V., Ramaekers F.C.S., Klein R.M., et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res. 48:1988;3221-3229.
12. Pendleton N., Myskow M.W., Green J.A. Expression of cytokeratins, involucrin and peanut agglutinin binding lectin in resected non-small cell lung carcinomas. Br. J. Cancer. 65:1992;37. (abstract).
13. Pendleton N., Occleston N.L., Walshaw M.J., et al. Simple cytokeratins in the serum of patients with lung cancer: relationship to cell death. Eur. J. Cancer. 30A:1994;93-96.
14. Hendrix M.J., Seftor E.A., Chu Y.W., Trevor K.T., Sftor R.E. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis. Rev. 15:1996;507-525.
15. Schaafsma H.E., Ramaekers F.C.S., van Muijen G.N.P., Robben H., Lane E.B., Leigh I.M., Ooms E.C.M., Schalken J.A., van Moorselaar R.J.A., Ruiter D.J. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. Am. J. Pathol. 139:1991;1389-1400.
16. Schaafsma H.E., van der Velden L.A., Manni J.J., et al. Increased expression of cytokeratin 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J. Pathol. 170:1993;77-86.
17. Modjtahedi N., Frebourg T., Fossar N., Lavialle C., Cremisi C., Brison O. Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell line. Exp. cell Res. 201:1992;74-82.
18. Chu Y.W., Runyan R.B., Oshima R.G., Hendrix M.J.C. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. USA. 90:1993;4261-4265.
19. Chan R., Rossitto P.V., Edwards B.F., Cardiff R.D. Presence of proteolytically processed keratins in the culture media of MCF-7 cells. Cancer Res. 46:1986;6353-6359.
20. Bjorklund B., Bjorklund V. Specificity and basis of the tissue polypeptide antigen. Cancer Detec. Prevent. 6:1983;411-450.
21. Sundstorm B., Stigbrand T. A two-site enzyme-linked immunosorbent assay for cytokeratin 8. Int. J. Cancer. 46:1990;604-609.
22. Ueda Y., Bandoh S., Fujita J., Sato M., Yamaji Y., Takahara J. Expression of nerve growth factor-induced clone B subfamily and pro-opiomelanocortin gene in lung cancer cell lines. Am. J. Respir. Cell Mol. Biol. 20:1999;1319-1325.
23. Traweek S.T., Liu J., Battifora H. Keratin gene expression in non-epithelial tissues: Detection with polymerase chain reaction. Am. J. Pathol. 142:1993;1111-1118.
24. Ebert W., Hoppe M., Muley T., Drings P. Monitoring of therapy in inoperable lung cancer patients by mesurement of CYFRA 21-1, TPA-M, TPS, CEA, and NSE. Anticancer Res. 17:1997;2875-2878.
25. Luning B., Nilsson U. Sequence homology between TPA and intermediate filament proteins. Acta Chem. Scand. 37:1983;731-753.
26. Weber K., Osborn M., Moll R., Wiklund B., Luning B. Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non squamous epithelia: re-evaluation of a human tumor marker. EMBO J. 3:1984;2707-2714.
27. Aquilina R., Bergero F., Magri G., Noceti P., Mirabelli S. Trials of the diagnostic potentials of TPA in tumorous and nontumorous lung pathologies in 303 cases. Minerva Med. 83:1992;415-419.
28. Lai R.S., Hsu H.K., Lu J.Y., Ger L.P., Lai N.S. CYFRA 21-1 enzyme-linked immunosorbent assay: Evaluation as a tumor marker in non-small cell lung cancer. Chest. 109:1996;995-1000.
29. Dohmoto K., Hojo S., Fujita J., et al. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines. Int. J. Cancer. 91:2001;468-473.
30. Silen A., Westlin J.E., Letocha H., Wiklund B., Ekblom J., Nilsson S. Nobel monoclonal antibodies reactive with cytokeratin 8 and 18. Immunocyt Immunohist Immunoscint Antibody Immunoconj. Radiopharmaceut. 7:1994;179-194.
31. Bauer T., Muhrer K.H., Muller H., Grebe S.F. Short-term and long-term monitoring of the serum level of TPA after radical resection of gastrointestinal or lung cancer. Nucl. Med. Commun. 7:1986;121-127.
32. Owaribe K., Nishizawa Y., Franke W.W. Isolation and characterization of hemidesmosomes from bovine corneal epithelial cells. Exp. Cell Res. 192:1991;622-630.
33. Garrod D.R. Desmosomes and hemidesmosomes. Curr. Opin. Cell Biol. 5:1993;30-40.
34. Fujita J., Dobashi N., Ohtsuki Y., et al. Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell lines. Br. J. Cancer. 81:1999;769-773.